Skip to main content

A Phase 1b/2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Subjects with Severe Sepsis

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Bristol-Myers Squibb Company

Start Date

November 2, 2015

End Date

September 20, 2017
 

Administered By

Ophthalmology

Awarded By

Bristol-Myers Squibb Company

Start Date

November 2, 2015

End Date

September 20, 2017